VB

Veena Beloor Ganapayya Bairy

Active Director Director DIN 00452561
DIN 00452561 First appointment Feb 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Feb 2004
Shareholding value •••• Premium profile

About Veena Beloor Ganapayya Bairy

Data last updated:

Veena Beloor Ganapayya Bairy is a Director at Beloorbayir Biotech Limited (since 2005) and Director at Bayir Extracts Private Limited (since 2004). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹72.27 Cr; the largest is Beloorbayir Biotech Limited at ₹67.42 Cr (FY 2021). Earlier, Veena Beloor Ganapayya Bairy was a Director at Bayir Chemicals Private Limited (from 2012) and Director at Bayir Chemicals India Private Limited (from 2014) and 2 more.

DIN 00452561
Primary Designation Director
Industry Pharma
First Appointment 27 Feb 2004
Oldest Company Age 32 yrs
Largest company Beloorbayir Biotech Limited · ₹67.42 Cr (FY 2021)
Combined revenue ₹72.27 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beloorbayir Biotech Limited U73100KA2005PLC035741
Director02 Mar 20052005₹67.42 Cr (FY 2021)Active
Bayir Extracts Private Limited U24111KA1994PTC015193
Director27 Feb 20041994₹4.85 Cr (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bayir Chemicals Private Limited U24100KA2012PTC063929
Director10 May 20122012₹2.3 Lakh (FY 2017)Strike Off
Director03 Jul 20142014Strike Off
Sneha Natura India Private Limited U24232KA2014PTC075181
Director03 Jul 20142014Strike Off
Sneha Natura Private Limited U24233KA2012PTC063958
Director11 May 20122012₹2.1 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Veena Beloor Ganapayya Bairy

Directorship timeline

Open interactive timeline →
Bayir Chemicals Private Limited
Bayir Chemicals India Private Limited
Beloorbayir Biotech Limited
Sneha Natura India Private Limited
Premium access

Shareholding and investment profile for Veena Beloor Ganapayya Bairy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veena Beloor Ganapayya Bairy

Veena Beloor Ganapayya Bairy currently holds 2 directorships: Beloorbayir Biotech Limited (Director, since 02 Mar 2005, revenue ₹67.42 Cr (FY 2021)); Bayir Extracts Private Limited (Director, since 27 Feb 2004, revenue ₹4.85 Cr (FY 2021)).

Veena Beloor Ganapayya Bairy was first appointed on 27 Feb 2004 as Director at Bayir Extracts Private Limited. The most recent appointment on record is 03 Jul 2014 at Sneha Natura India Private Limited.

The 2 current companies of Veena Beloor Ganapayya Bairy that report revenue have a combined latest revenue of ₹72.27 Cr: Beloorbayir Biotech Limited ₹67.42 Cr (FY 2021); Bayir Extracts Private Limited ₹4.85 Cr (FY 2021).

Veena Beloor Ganapayya Bairy held 4 earlier board appointments: Bayir Chemicals Private Limited (Director, from 10 May 2012); Bayir Chemicals India Private Limited (Director, from 03 Jul 2014); Sneha Natura India Private Limited (Director, from 03 Jul 2014); Sneha Natura Private Limited (Director, from 11 May 2012).

The current boards of Veena Beloor Ganapayya Bairy's companies include Ajay Ganapayya Bairy (Beloorbayir Biotech Limited), Arvind Raghavan (Beloorbayir Biotech Limited), Ashok Sinha (Beloorbayir Biotech Limited), Beloor Ganapayya Bairy (Beloorbayir Biotech Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available